Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$25,584,742
+$21,169,043 QoQ
Shares Held
101,672
+400.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
3.48%
of 13F equity value
Holder Rank
#532
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $56,704,468 across 12 Drug Manufacturers - General names. ABBV ranks #1 (45.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
101,672 | $25,584,742 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
208,112 | $11,991,413 | |
| 3 | JNJ |
Johnson & Johnson
|
24,544 | $6,233,439 | |
| 4 | LLY |
ELI LILLY & Co
|
3,906 | $4,684,973 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,163 | $2,590,945 | |
| 6 | PFE |
Pfizer Inc
|
58,088 | $1,398,759 | |
| 7 | NVS |
Novartis AG
|
8,591 | $1,346,381 | |
| 8 | AMGN |
Amgen Inc
|
3,665 | $1,327,169 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,584,742 | 101,672 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $4,415,699 | 20,303 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,381,524 | 19,176 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $4,421,950 | 19,098 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,911,264 | 15,684 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,296,797 | 15,735 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,781,360 | 15,652 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $3,158,495 | 15,994 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,781,711 | 16,218 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,959,489 | 16,252 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $14,674,264 | 94,691 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $14,187,530 | 95,180 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $13,087,672 | 97,140 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $15,372,352 | 96,457 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $15,542,680 | 96,174 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $12,760,015 | 95,075 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $14,516,964 | 94,783 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $15,489,934 | 95,552 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $12,899,964 | 95,273 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $10,102,025 | 93,650 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $10,529,361 | 93,478 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $10,121,600 | 93,528 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $9,985,201 | 93,189 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||